A research-and-development practice building the verification, generation, and decision-integrity layer for modern biotech — engineered to run where the science lives.
Biotech doesn’t buy software. It buys confidence, auditability, and regulatory acceptance — and it cannot let its most valuable data leave the building to get them.
BioAuditIQ™
Scientific decision integrity
The current state
Research, biomarker, and target decisions are made on packages no one has independently checked — and the cost of advancing the wrong one is measured in years and millions.
The outcome
An independent integrity layer that examines the data, the conclusions, and the regulatory package together — surfacing what was missed before a program commits to it. Runs entirely within the organization.
TrialStat™
Clinical evidence, generation-ready
The current state
The statistical outputs every submission depends on remain slow, specialist-bound, and expensive to produce — a bottleneck between trial data and regulatory readiness.
The outcome
Trial data becomes submission-ready evidence — the analyses, tables, and reporting regulators expect, generated on demand and fully audit-traceable, without the programming overhead. Patient data never leaves the company.
LabBridge™
Data, made analysis-ready
The current state
Scientific data arrives fragmented across instruments, systems, and formats — and the effort to reconcile it consumes the time meant for discovery.
The outcome
One clean, structured, analysis-ready foundation — reconciled locally, with a complete record of every transformation. The groundwork the entire pipeline depends on, done once and done defensibly.